Chinese biomedical researcher Jiankui He. (Photo credit: Wikimedia)

Follow the money: What the sources of Jiankui He’s funding reveal about what Beijing authorities knew about illegal CRISPR babies, and when they knew it

https://thebulletin.org/wp-content/uploads/2020/08/He_Jiankui_cropped-150x150.jpg

Chinese biomedical researcher Jiankui He. (Photo credit: Wikimedia)

When news broke in November 2018 that the first gene-edited human babies had been born in an experiment conducted by Jiankiu He, an associate professor at Southern University of Science and Technology (SUStech) in Shenzhen, the initial reaction from Chinese authorities was  positive. Indeed, the People’s Daily—official newspaper of China’s Communist Party—used the words “milestone achievement” to describe the twin girls’ birth.

Jiankiu He had used the gene-editing technique known as CRISPR-Cas9 in an attempt to replicate a mutation in the CCR5 gene known to offer immunity to the HIV virus. This mutation—known as CCR5Δ32—occurs naturally among about 10 percent of the Northern European population, but rarely in China. He said that he had conducted the work because he’d wanted to give the resulting babies immunity against HIV, and that he thought his work would be met with praise. Instead, as soon as news of his work was revealed—by MIT’s Technology Review, in late November 2018 (Regalado 2018)—negative feedback started rolling in, particularly at the Second International Summit on Human Genome Editing, in Hong Kong, which coincidentally took place a few days after the publication of the MIT article, and where He presented his research (He Q&A 2018). Scientists described He’s work as ethically irresponsible, saying that among other things, the use of CRISPR-Cas9 for human reproduction has not been proven safe.

As the Russian invasion of Ukraine shows, nuclear threats are real, present, and dangerous

The Bulletin elevates expert voices above the noise. But as an independent, nonprofit media organization, our operations depend on the support of readers like you. Help us continue to deliver quality journalism that holds leaders accountable. Your support of our work at any level is important. In return, we promise our coverage will be understandable, influential, vigilant, solution-oriented, and fair-minded. Together we can make a difference.



 

Get alerts about this thread
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

ALSO IN THIS ISSUE

RELATED POSTS